# Brookdale Senior Living Inc. (BKD)

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-29  
**Report type:** Primer (steps 1–3 of 19)  
**API endpoint:** GET /api/v1/research/BKD/primer

## Business Model

---
source: coverage-next-full | ticker: BKD | step: "01" | created: 2026-05-29
---

### Step 01 — Company Overview: Brookdale Senior Living Inc. (BKD)

#### Company at a Glance
Brookdale Senior Living Inc. (NYSE: BKD) is the largest operator of senior living communities in the United States. As of Q1 2026, the company operates approximately 576 communities serving ~51,000 residents across 41 states. The company offers a full spectrum of senior care including independent living (IL), assisted living (AL), memory care (MC), and continuing care retirement communities (CCRCs).

---

#### Business Description

##### What BKD Does
Brookdale operates senior living communities on both an owned and leased basis. Its residents are primarily private-pay seniors who require varying levels of care:
- **Independent Living (IL):** Minimal care; lifestyle-focused amenities; targeted at active seniors 65+
- **Assisted Living (AL):** Daily activity assistance, medication management; highest volume segment
- **Memory Care (MC):** Specialized dementia/Alzheimer's care; highest acuity and highest revenue per unit
- **CCRCs (Continuing Care Retirement Communities):** Multi-level campuses offering IL + AL + MC continuum

##### Revenue Model
- **Resident fees** comprise ~95%+ of total revenue (~$3.0B of $3.2B in FY2025)
- Monthly fees are set contractually based on unit type, care level, and geographic market
- Rate increases are negotiated annually; typical rate increases of 5–9% in 2025–2026
- **Management fees** (~$150M): BKD manages communities owned by third-party REITs for a fee

---

#### Scale & Geographic Footprint

| Period | Communities | Residents | States |
|---|---|---|---|
| Pre-COVID (2019) | ~900 | ~90,000 | 46 |
| FY2022 | ~736 | ~74,000 | 44 |
| FY2024 | ~673 | ~67,000 | 41 |
| FY2025 | ~647 | ~51,000 | 41 |
| Q1 2026 | ~576 | ~47,000 | 41 |

*Note: Portfolio rationalization via Ventas lease restructuring and non-renewal of underperforming leases drove community count decline.*

---

#### Leadership

##### Current Management Team
- **Nikolas W. Stengle** — President & CEO (since October 6, 2025)
  - Previously at Gentiva Health Services and Sunrise Senior Living
  - Strategic focus: operational excellence, real estate value creation, occupancy growth
- **Dawn Kussow** — EVP & CFO
  - Retained through CEO transition; oversaw 2024–2025 debt refinancing
- **Denise Warren** — Board Chairman
  - Was Interim CEO April–October 2025 following Cindy Baier's departure

##### Previous CEO — Cindy Baier (2018–April 2025)
- Led the company through COVID-era survival (2020–2021)
- Negotiated Ventas lease restructuring (reduced obligations by ~55 communities)
- Executed sequential rounds of debt refinancing
- Departed April 2025; Board stated new leadership needed to "capitalize on intrinsic value of owned real estate"

---

#### Ownership & Portfolio Structure

##### Community Ownership Types (as of ~early 2025)
- **Owned (~383 communities):** BKD owns real estate + operates; provides asset value backstop
- **Leased (~236 communities pre-restructuring):** BKD leases from REITs and third parties; Ventas is largest lessor
- **Managed (~28 communities):** BKD manages for a fee; no lease/ownership risk

##### Key REIT Relationship — Ventas (VTR)
- Ventas was BKD's largest landlord, originating from the 2014 Emeritus merger
- **2024 master lease restructuring:** 120-community portfolio → 65 renewed + 55 transitioned to Ventas for sale/re-leasing
- Effective Jan 2026: 55 low-performing communities removed from BKD's portfolio
- Outcome: removes ~6,125 units of lease obligation; improves BKD's per-community EBITDA metrics

---

#### Investment Thesis (Overview Level)
**Bull case in one sentence:** BKD is a high-operating-leverage senior living operator at an inflection point — every 100bps of occupancy gain above the ~80% fixed-cost break-even threshold flows through at very high incremental margin, and the baby boomer demographic wave provides a 15-year secular demand tailwind.

**Bear case in one sentence:** $4.3B in debt plus $1.2B in lease liabilities creates an existential refinancing risk that could wipe out equity holders if occupancy growth stalls or capital markets tighten, and persistent GAAP net losses ($200M+/year) reflect the true cash burden of the capital structure.

---

#### Quick Financial Snapshot (FY2025)
| Metric | Value |
|---|---|
| Revenue | $3.194B |
| Adjusted EBITDA | $457.8M |
| Net Income | $(262.7)M |
| Free Cash Flow | $16M (first positive FCF since 2019) |
| Weighted Avg Occupancy | 80.9% |
| RevPAR | $5,134/month |
| Market Cap | ~$3.2B |
| Long-Term Debt | $4.3B |
| Cash | $279M |

## Financial Snapshot

---
source: coverage-next-full | ticker: BKD | step: "04" | created: 2026-05-29
---

### Step 04 — Financial Snapshot: Brookdale Senior Living Inc. (BKD)

#### Why GAAP Net Income Is the Wrong Lens for BKD

Brookdale has reported GAAP net losses every year since 2018 (except FY2020, which was distorted by asset sales and CARES Act relief). The reason is structural: high D&A ($370M/year on aging physical plants), rent expense on leased communities, and interest expense on $4.3B of debt together create an accounting loss even as cash flow improves.

**The correct BKD profitability framework:**
1. **Adjusted EBITDA** — earnings before interest, taxes, D&A, and non-cash/non-recurring items
2. **Adjusted EBITDAR** — adds back rent expense; the "pre-landlord" operating profitability measure
3. **RevPAR / Occupancy trends** — the leading indicator of fundamental performance

---

#### Income Statement Summary (FY2021–FY2025)

| Metric (USD millions) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| **Total Revenue** | $2,758 | $2,825 | $3,016 | $3,125 | $3,194 |
| YoY Growth | -22.1% | +2.4% | +6.8% | +3.6% | +2.2% |
| Resident Fee Revenue | — | — | $2,824 | $2,972 | $3,043 |
| Facility Operating Expense | — | — | — | $2,183 | $2,216 |
| **Gross Profit (est.)** | — | — | ~$600 | ~$789 | ~$827 |
| G&A Expense | — | — | — | $186 | $195 |
| **Operating Income** | $(217) | $(43) | $18 | $47 | $14 |
| Interest Expense (est.) | ~$(280) | ~$(270) | ~$(260) | ~$(275) | ~$(295) |
| **Net Income** | $(99) | $(238) | $(189) | $(202) | $(263) |
| **EPS (Basic)** | $(0.54) | $(1.25) | $(0.84) | $(0.89) | $(1.12) |
| D&A | $345 | $354 | $350 | $368 | $370 |
| SBC | $16 | $15 | $12 | $14 | $12 |
| CapEx | $177 | $197 | $233 | $201 | $202 |

---

#### Adjusted EBITDA — The Key Metric

| Metric (USD millions) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026E (Guidance) |
|---|---|---|---|---|---|
| Net Income | $(238) | $(189) | $(202) | $(263) | — |
| + D&A | $354 | $350 | $368 | $370 | — |
| + Interest | ~$270 | ~$260 | ~$275 | ~$295 | — |
| + Non-cash/non-rec | — | — | — | — | — |
| **Adjusted EBITDA** | — | — | $386 | $458 | $502–$516 |
| YoY Growth | — | — | — | +18.5% | +9.7–12.7% |

The FY2024 → FY2025 EBITDA improvement of $71.6M (+18.5%) demonstrates the operating leverage when occupancy improves 230bps and RevPOR increases 2.7%. The 2026 guidance of $502–516M implies continued acceleration.

---

#### FY2025 Detailed P&L (From Investor Presentation)

| Item | FY2025 | FY2024 | Change |
|---|---|---|---|
| Resident Fee Revenue | $3,042.7M | $2,972.1M | +$70.6M (+2.4%) |
| Facility Operating Expense | $2,216.0M | $2,183.3M | +$32.7M (+1.5%) |
| **Facility Operating Margin** | **27.2%** | **26.5%** | **+70bps** |
| G&A Expense | $195.1M | $185.9M | +$9.2M (+5.0%) |
| Adjusted EBITDA | $457.8M | $386.2M | +$71.6M (+18.5%) |
| Net Income (Loss) | $(262.7)M | $(202.0)M | -30.1% |

*Revenue growing faster than facility OpEx (+2.4% vs. +1.5%) = positive operating leverage.*
*Net loss widening despite EBITDA growth = interest + D&A burden on growing debt balance.*

---

#### Cash Flow Summary

| Metric (USD millions) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $(95) | $3 | $163 | $166 | $218 |
| Capital Expenditures | $(177) | $(197) | $(233) | $(201) | $(202) |
| **Free Cash Flow** | $(272) | $(194) | $(70) | $(35) | **+$16** |

**FY2025 marks the first positive FCF year since pre-COVID.** FCF of $16M is thin but directionally significant — the company is no longer burning cash on operations. With occupancy recovery continuing, FCF should expand meaningfully in 2026–2027.

---

#### Balance Sheet Summary

| Metric (USD millions) | FY2023 | FY2024 | FY2025 | Q1 2026 |
|---|---|---|---|---|
| Total Assets | $5,573 | $6,336 | $5,952 | $5,898 |
| Cash & Equivalents | $278 | $309 | $279 | $265 |
| Long-Term Debt | $3,697 | $4,063 | $4,293 | $4,307 |
| Operating Lease Liability | — | — | $1,198 | — |
| Finance Lease Liability | — | — | $26 | — |
| Stockholders' Equity | — | — | $(45) | $(56) |
| Retained Deficit | — | — | $(4,303) | $(4,309) |

**Total obligation stack:** ~$4.3B debt + ~$1.2B operating leases = ~$5.5B in obligations against $279M cash and $458M EBITDA. Net leverage (debt/EBITDA) ~9x before leases. Lease-adjusted EBITDAR provides a more useful framing but still implies elevated leverage.

---

#### EPS Trend — Loss Trajectory

| Year | EPS (Basic) | Comment |
|---|---|---|
| FY2019 | $(1.44) | Pre-COVID losses |
| FY2020 | $0.45 | CARES Act relief + asset sales (not recurring) |
| FY2021 | $(0.54) | COVID trough |
| FY2022 | $(1.25) | Interest burden; occupancy recovering |
| FY2023 | $(0.84) | Operating income turns positive |
| FY2024 | $(0.89) | EBITDA improving; interest expense rising |
| FY2025 | $(1.12) | Deeper loss vs. 2024 due to $263M net loss |
| FY2026E | ~$(0.37) | Consensus; major improvement expected |
| FY2027E | ~$(0.14) | Approaching breakeven |

The path to GAAP EPS breakeven requires either: debt reduction (lowers interest expense), or EBITDA growth sufficient to cover ~$295M annual interest + $370M D&A. At current trajectory, EPS breakeven appears achievable around 2028–2029 absent transformative transactions.

---

#### Key Financial Ratios (FY2025)

| Ratio | Value | Comment |
|---|---|---|
| EV/Adj. EBITDA | ~15.6x | Moderate for recovery story; high vs. REIT sector |
| Adj. EBITDA Margin | 14.3% | Improving; facility-level margin ~27% |
| Debt/EBITDA (gross) | ~9.4x | Elevated; market accepted given owned real estate backing |
| Free Cash Flow Yield | ~0.5% | Thin; improving |
| Revenue Growth (3-yr CAGR) | ~5.0% | Understated due to portfolio shrinkage |

---

#### Important Notes on BKD Financial Reporting

1. **Non-GAAP adjusted EBITDA** is the company-reported metric BKD guides to. Excludes non-cash items, transaction costs, legal settlements.
2. **Same-community metrics** are the cleanest view of underlying performance, stripping out acquisitions, dispositions, and Ventas transitions.
3. **EBITDAR** (adds back rent expense) is used for covenant compliance and peer comparison — particularly relevant given $1.2B lease liability.
4. **Revenue decline (FY2025→FY2026E)** is structural/portfolio, not operational — same-community RevPAR growing 8–9%.

## Recent Catalysts

---
source: coverage-next-full | ticker: BKD | step: "12" | created: 2026-05-29
---

### Step 12 — Catalysts: Brookdale Senior Living Inc. (BKD)

#### Near-Term Catalysts (6–18 months)

##### 1. Occupancy Crossing 83–84%
- Q1 2026 consolidated occupancy: 82.1%; month-end April 2026: 83.4%
- Management guidance implies ~83%+ weighted average for FY2026
- Each 100bps of occupancy gain above 82% = ~$25–35M incremental EBITDA at current scale
- **Catalyst:** Q2/Q3 2026 occupancy prints above 83% validate the recovery trajectory; analyst estimates revise upward

##### 2. FY2026 EBITDA Guidance Beat
- Guidance: $502–516M adjusted EBITDA
- If RevPAR growth tracks at 8–9% AND labor normalization continues: potential for $520–540M
- **Catalyst:** Q2 2026 earnings beat signals EBITDA acceleration; stock typically re-rates on beats for recovery stories

##### 3. Real Estate Monetization Announcement
- New CEO Stengle explicitly tasked with "capitalizing on intrinsic value of owned real estate"
- Potential transactions: partial sale-leaseback to Welltower/Ventas, joint venture, RIDEA conversion
- **Catalyst:** Any announcement of real estate transaction (even small pilot) could re-rate the stock significantly (real estate embedded value story)

##### 4. Debt Reduction / Liability Management
- FCF turned positive in FY2025 ($16M); could reach $50–100M by FY2027
- Any announced debt paydown or tender offer for high-cost debt = leverage reduction signal
- **Catalyst:** Balance sheet improvement narrative; reduces solvency risk premium in equity valuation

---

#### Medium-Term Catalysts (18 months–3 years)

##### 5. Baby Boomer Wave Inflection (2026–2030)
- First Boomers turned 80 in 2025 — prime assisted living demand age
- By 2028, the early Boomer cohort will be 82–84; AL demand surge accelerating
- **Catalyst:** Multi-year structural occupancy demand that cannot be met by limited new supply pipeline

##### 6. Labor Market Normalization Completion
- Agency staffing normalization is ongoing; full normalization could take another 1–2 years
- If agency staffing as % of total labor hours reaches pre-COVID levels, additional $20–40M EBITDA
- **Catalyst:** Management disclosure of normalized agency hours; operating expense guidance revision

##### 7. CEO Strategy Update / Investor Day
- Stengle has not held a major investor day (new as of Oct 2025)
- An investor day with updated long-term targets, real estate strategy, and capital structure plan = re-rating catalyst
- **Catalyst:** Forward-looking narrative shift; clarity on "what BKD looks like at 85% occupancy"

---

#### Long-Term Catalysts (3+ years)

##### 8. GAAP EPS Breakeven
- Analyst consensus: FY2026E EPS $(0.37); FY2027E EPS $(0.14)
- If trajectory continues, first GAAP-profitable year possible around 2028–2029
- **Catalyst:** Removal of "loss-making company" stigma; broader institutional ownership eligible

##### 9. Leverage Normalization
- Net debt/EBITDA declining from ~9x toward 6–7x (achievable by FY2027–2028)
- Investment-grade credit trajectory would dramatically reduce cost of capital and equity valuation
- **Catalyst:** Credit upgrade discussions; access to bond markets at lower rates

---

**Bull Case**
- Baby boomer demographic wave drives occupancy from 82% to 87%+ over 3–5 years, creating ~$150–200M in incremental EBITDA via high operating leverage; combined with RevPOR increases of 5–8%/year, EBITDA could reach $700M+ — implying EV/EBITDA re-rating and stock 2–3x from current levels
- New CEO Stengle monetizes a portion of the owned real estate portfolio (sale-leaseback or JV with Welltower/Ventas), converting hidden real estate value into debt reduction and demonstrating the equity is worth $20–25/share at conservative cap rates
- Labor cost normalization (agency staffing back to pre-COVID levels + moderate wage growth) adds $30–50M EBITDA independently of occupancy gains, accelerating FCF to $100M+ and enabling debt paydown

**Bear Case**
- Occupancy recovery stalls at 82–83% due to competitive new supply, economic softness, or a health event, leaving BKD below the EBITDA trajectory needed to service $4.3B of debt plus refinance 2027+ maturities — eventually forcing a dilutive equity raise or debt restructuring
- Labor cost inflation re-accelerates (state minimum wage hikes, CNA shortages, unionization) adding $50–100M in annual facility operating expense, collapsing the margin expansion thesis and returning FCF to negative territory
- Capital markets tighten or BKD-specific credit deteriorates before the 2027–2032 debt walls are fully addressed, creating a refinancing crisis where equity holders are diluted or wiped out — the binary outcome risk inherent in a 9x levered turnaround

## Full Research Available

This primer covers steps 1–3 of 19. The full deep dive (moat analysis, DCF, bull/bear,
management quality, earnings transcript analysis) is available via:

- Investment memo: /memo/bkd
- Full research API: GET /api/v1/research/BKD/memo
- Coverage universe: /stocks